EPSN
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 45 | 0 | 7.10M | $38.40M | +3 | −3 |
| Q1 2026 | 47 | 0 | 6.85M | $42.21M | +4 | −4 |
| Q4 2025 | 47 | -2 | 6.50M | $30.17M | — | −2 |
| Q3 2025 | 17 | +2 | 4.28M | $21.57M | +2 | — |
| Q2 2025 | 12 | +2 | 4.52M | $33.37M | +2 | — |
| Q1 2025 | 7 | +1 | 1.75M | $12.33M | +1 | — |
| Q4 2024 | 6 | 0 | 1.61M | $10.00M | — | — |
| Q3 2024 | 5 | +1 | 1.55M | $9.08M | +1 | — |
| Q2 2024 | 4 | — | 1.55M | $8.43M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 1.11M | — | $6.06M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 218.71K | — | $1.19M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | Renaissance Technologies ✦ | 183.98K | — | $1.00M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Two Sigma Investments ✦ | 32.06K | — | $174,722 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 99 holders, 21.28M shares, $130.99M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer, Director · Chief Executive… · 13.47K sh @ 5.93 · $79,859
Officer, Director · Chief Executive… · 1.43K sh @ 5.90 · $8,437
Officer, Director · Chief Executive… · 8.21K sh @ 5.88 · $48,257
Officer, Director · Chief Executive… · 21.41K sh @ 5.63 · $120,470
Officer, Director · Chief Executive… · 4.90K sh @ 5.56 · $27,244
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology